CC BY-NC-ND 4.0 · Indian J Med Paediatr Oncol 2009; 30(S 01): 38-45
DOI: 10.1055/s-0041-1733342
Original Article

Metastatic Tumours in Ovaries

Prasenjit Das
Department of Pathology, All India institute of Medical Sciences, New Delhi, India
Narender Kumar
Department of Pathology, All India institute of Medical Sciences, New Delhi, India
Siddhartha DATTA Gupta
Department of Pathology, All India institute of Medical Sciences, New Delhi, India
› Author Affiliations

Publication History

Article published online:
02 March 2022

© 2009. Indian Society of Medical and Paediatric Oncology. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial-License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (

Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India

  • References

  • 1 Arguello F, Baggs RB, Eskenazi AE, Duerst RE, Frantz CN. Vascular anatomy and organ-specific tumour growth as critical factors in the development of metastases and their distribution among organs. Int J Cancer 1991; 48: 583-90.
  • 2 Moore RG, Chung M, Granai GO, Gajewski W, Steinhoff MM: Incidence of metastasis to the ovaries from nongenital tract tumours. Gynecol Oncol, 2004; 93: 87-91.
  • 3 Yada-Hashimoto N, Yamamoto T, Kamiura S, Seino H, Ohira H, Sawai K, Kimura T, Saji F: Metastatic ovarian tumours: a review of 68 cases. Gynecol Oncol, 2003; 89: 314-317.
  • 4 Ulbright TM, Roth LM, Stehman FB: Secondary ovarian neoplasia: a clinicopathologic study of 35 cases. Cancer, 1984; 53: 1164-1174.
  • 5 Young RH, Path FRC, Scully RE: Metastatic tumours of the ovary. In: Blaustein’s pathology of the female genital tract,Kurman RJ (Ed), pp 1063-1101, Springer-Verlag, New York, 2002.
  • 6 Prat J, editor. Pathology of the ovary. Philadelphia: Saunders; 2004.
  • 7 Singh N, Lowe D. Metastases in the ovary. In: Jakobs IJ, Shepherd JH, Oram DH, Blackett AD, Lu-esley DM, Berchuck A, et al. editors. Ovarian cancer. 2nd edition. Oxford: University Press; 2002. p. 85-9.
  • 8 Young RH, Hart WR. Metastases from carcinoma of the pancreas simulating primary mucinous tumours of the ovary. A report of seven cases. Am J Surg Pathol 1989;13(7):748-56.
  • 9 Petru E, Pickel H, Heydarfadai M, Lahousen M, Haas J, Schaider H, et al. Nongenital cancers metastatic to ovary. Gynecol Oncol 1992;44(1): 83-6.
  • 10 Hann L, Lui D, Shi W, Bach A, Selland DL, Castieli M. Adnexal masses in women with breast cancer:cUS findings with clinical and histopathologic correlation. Radiology 2000;216:242-7.
  • 11 Tornos C, Soslow R, Chen S, Akram M, Hummer AJ, Abu-Rustum N, et al. Expression of WT1, CA 125 and GCDFP-15 as useful markers in the differential diagnosis of primary ovarian carcinomas versus metastatic breast cancer to the ovary. Am J Surg Pathol 2005;29(11):1482-9.
  • 12 Greene HJ, Grusetz MW, Mackles A: Subsequent second primary and metastatic cancer of the ovary. Clin Obstet Gynecol 1969;12: 972–979.
  • 13 Webb MJ, Decker DG, Mussey E: Cancer metastatic to the ovary:Factors influencing survival. Obstet Gynecol 1975;45:391–396.
  • 14 Mazur MT, Hsueh S, Gersell DJ: Metastases to the female genital tract. Analysis of 325 cases. Cancer 1984;53:1978–1984.
  • 15 Demopoulos RI, Touger L, Dubin N: Secondary ovarian carcinoma: A clinical and pathological evaluation. Int J GynecolPathol 1987;6:166–175.
  • 16 Gagnon Y, Tetu B: Ovarian metastases of breast carcinoma.A clinicopathologic study of 59 cases. Cancer 1989;64:892–898.
  • 17 Petru E, Pickel H, Heydarfadai M, et al.: Nongenital cancersmetastatic to the ovary. Gynecol Oncol 1992;44:83–86.
  • 18 Fujiwara K, Ohishi Y, Koike H, Sawada S, Moriya T, Kohno I:Clinical implications of metastases to the ovary. Gynecol Oncol 1995;59:124–128.
  • 19 Yada-Hashimoto N, Yamamoto T, Kamiura S, et al.: Metastatic ovarian tumours: A review of 64 cases. Gynecol Oncol 2003;89: 314–317.
  • 20 Moore RG, Chung M, Granai CO, et al.: Incidence of metastasis to the ovary from nongenital tract primary tumours. Gynecol Oncol 2004;93:87–91.
  • 21 Ayhan A, Guvenal T, Salman MC, et al.: The role of cytoreductive surgery in nongenital cancers metastatic to the ovaries. Gynecol Oncol 2005;98:235– 241.
  • 22 Skirnisdottir I, Garmo H, Holmberg L: Non-genital tract metastases to the ovaries presented as ovarian tumours in Sweden 1990–2003: Occurrence, origin and survival compared to ovarian cancer. Gynecol Oncol 2007;105:166–171.
  • 23 Kiyokawa T, Young RH, Scully RE: Krukenberg tumours of the ovary: A clinicopathologic analysis of 120 cases with emphasis on their variable pathologic manifestations. Am J Surg Pathol 2006;30.
  • 24 Young RH, Scully RE. Metastatic tumours of the ovary. In: Kurman RJ, editor. Blaustein´s Pathology of the Female Genital Tract. 5th edition . New York: Springer-Verlag; 2002.p.1063-101.
  • 25 Mandai M. Krukenberg tumour. CME J Gynaec Oncol. 2004; 4: 112-14.
  • 26 Wright TC,Felix JC. Symptoms are bilateral masse. Contemporary OB/Gynar archive,1996. http:// data/1996/0900/g9a061.html
  • 27 Prat J, Morice P. Secondary tumours of the ovary. In: Tavassoli FA, Devilee P, editors. World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of the Breast and Female Genital Organs.Lyon:IARC Press; 2003. p.193-6.
  • 28 Ronnett BM, Kurman RJ, Shmookler BM, et al. The morphologic spectrum of ovarian metastases of appendiceal adenocarcino-mas: a clinico-pathologic and immunohistochemical analysis of tumours often misinterpreted as primary ovarian tumours or metastatic tumours from other gastrointestinal sites. Am J Surg Pathol 1997;21: 1144-55.
  • 29 Householder, JeanMarie, Han, Aaron, Edelson, Mitchell I, Eager, J Michael, Rosenblum, Norman G. Immunohistochemical confirmation of pulmonary papillary adenocarcinoma metastatic to ovaries. Arch Pathol Lab Med. 2002;126:1101-1103.
  • 30 Lee E S, Cho H D, Kim I. The usefulness of CK7 and colon ovarian tumour antigen in differential diagnoses of primary and metastatic ovarian neoplasms. Korean J Pathol. 1998; 32: 201-7.
  • 31 A. Guirguis, E. Elishaev, K. Timms, J. Reid, V. Abkevich, A. Gutin, J. Launchbury, K. Zorn, D. Deloia. Characterization of concurrent ovarian and endometrial carcinoma by copy-number analysis (CNA) and gene expression profiling (GEP). Clin Oncology, 2007 ASCO Annual Meeting Proceedings Part I. Vol 25, No. 18S (June 20 Supplement), 2007: 10546.
  • 32 Irving JA, Catasus L, Gallardo A, Bussaglia E, Romero M, Prat J. Synchronous endometrioid carcinomas of the uterine corpus and ovary: alterations in the beta-catenin (CTNNB1) pathway are associated with independent primary tumours and favorable prognosis. Hum Pathol 2005;36(6):605- 19.
  • 33 Mittal K, Soslow R, McCluggage W G. Application of Immunohistochemistry to Gynecologic Pathology. Archives Pathol Lab Medicine. 2008; 5: 13.
  • 34 Peiguo Chu, M.D., Ph.D., Emerald Wu, B.S., Lawrence M Weiss, M.D. Cytokeratin 7 and Cytokeratin 20 Expression in Epithelial Neoplasms: A Survey of 435 Cases. Mod Pathol 2000;13(9):962– 972.
  • 35 McCluggage WG, Young RH. Immunohistochemistry as a diagnostic aid in the evaluation of ovarian tumours. Semin Diagn Pathol. 2005;22 (1):3-32.